Novartis AG Total Non-Operating Income/Expense 2010-2024 | NVS
Novartis AG total non-operating income/expense for the twelve months ending June 30, 2024 was $-0.832B, a 31.85% increase year-over-year.
- Novartis AG annual total non-operating income/expense for 2023 was $-0.646B, a 15.99% decline from 2022.
- Novartis AG annual total non-operating income/expense for 2022 was $-0.769B, a 105.32% decline from 2021.
- Novartis AG annual total non-operating income/expense for 2021 was $14.448B, a 5372.99% decline from 2020.